144 related articles for article (PubMed ID: 26170662)
1. CaCO₃/CaIP₆ composite nanoparticles effectively deliver AKT1 small interfering RNA to inhibit human breast cancer growth.
Zhou H; Wei J; Dai Q; Wang L; Luo J; Cheang T; Wang S
Int J Nanomedicine; 2015; 10():4255-66. PubMed ID: 26170662
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of human bladder cancer growth by calcium carbonate/CaIP6 nanocomposite particles delivering AIB1 siRNA.
Wei J; Cheang T; Tang B; Xia H; Xing Z; Chen Z; Fang Y; Chen W; Xu A; Wang S; Luo J
Biomaterials; 2013 Jan; 34(4):1246-54. PubMed ID: 23127333
[TBL] [Abstract][Full Text] [Related]
3. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
He XW; Liu T; Xiao Y; Feng YL; Cheng DJ; Tingting G; Zhang L; Zhang Y; Chen YX; Tingting G; Zhang L
Cancer Biother Radiopharm; 2009 Apr; 24(2):249-59. PubMed ID: 19409048
[TBL] [Abstract][Full Text] [Related]
5. Transfer of siRNA against XIAP induces apoptosis and reduces tumor cells growth potential in human breast cancer in vitro and in vivo.
Zhang Y; Wang Y; Gao W; Zhang R; Han X; Jia M; Guan W
Breast Cancer Res Treat; 2006 Apr; 96(3):267-77. PubMed ID: 16341821
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
7. Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma.
Nakashiro K; Tanaka H; Goda H; Iwamoto K; Tokuzen N; Hara S; Onodera J; Fujimoto I; Hino S; Hamakawa H
Int J Oncol; 2015 Oct; 47(4):1273-81. PubMed ID: 26315674
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
[TBL] [Abstract][Full Text] [Related]
9. Short hairpin RNA-mediated gene silencing of ADAM17 inhibits the growth of breast cancer MCF‑7 cells in vitro and in vivo and its mechanism of action.
Hu B; Meng X; Zhang Y; Hossain MM; Wu L; Zhang Y; Peng X; Zhang X
Oncol Rep; 2018 Apr; 39(4):1640-1648. PubMed ID: 29393483
[TBL] [Abstract][Full Text] [Related]
10. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
[TBL] [Abstract][Full Text] [Related]
11. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles.
Zeng L; Li J; Li J; Zhang Q; Qian C; Wu W; Lin Z; Liang J; Chen Y; Huang K
Pancreas; 2015 Mar; 44(2):250-9. PubMed ID: 25401377
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
13. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.
Ma ZL; Chen YP; Song JL; Wang YQ
Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2394-9. PubMed ID: 26214774
[TBL] [Abstract][Full Text] [Related]
15. Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo.
Chen Z; Yu T; Zhou B; Wei J; Fang Y; Lu J; Guo L; Chen W; Liu ZP; Luo J
Biomaterials; 2016 Mar; 81():125-134. PubMed ID: 26731576
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
[TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
19. Effects of targeted nano-delivery systems combined with hTERT-siRNA and Bmi-1-siRNA on MCF-7 cells.
Liu L; Li H; Zhang M; Lv X
Int J Clin Exp Pathol; 2015; 8(6):6674-82. PubMed ID: 26261549
[TBL] [Abstract][Full Text] [Related]
20. Flash Nanoprecipitation Fabrication of PEI@Amorphous Calcium Carbonate Hybrid Nanoparticles for siRNA Delivery.
Ren Q; Wang L; Qian W; Chen B; Shuai Q; Yan Y
Macromol Biosci; 2023 Jul; 23(7):e2300085. PubMed ID: 37087721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
